NRG1 and melanoma: Furthermore, to confirm that phosphorylation of ErbB3 receptor is a consequence of increased NRG-1 production by melanoma cells we decided first to treat WM266 melanoma cells with vemurafenib (0.5 μM) or not for 24 h.